Published in Cancer on September 15, 1988
The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet (1999) 1.43
Giant cell tumor of bone: a neoplasm or a reactive condition? Int J Clin Exp Pathol (2008) 1.26
Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci U S A (1994) 1.09
Study of the cell biology and biochemistry of cherubism. J Clin Pathol (1998) 1.09
The diagnosis and management of giant cell lesions of the jaws. Ann Maxillofac Surg (2012) 1.06
Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation. J Cell Sci (2007) 1.00
Bone resorption by macrophage polykaryons of giant cell tumour of tendon sheath. Br J Cancer (1991) 0.99
RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. J Bone Miner Res (2007) 0.98
Peripheral giant cell granuloma. Contemp Clin Dent (2012) 0.91
Giant cell tumour of bone: new treatments in development. Clin Transl Oncol (2015) 0.87
Treatment of cherubism with salmon calcitonin: a case report. Eur J Dent (2011) 0.83
Fibrous dysplasia and central giant cell granuloma: a report of hybrid lesion with its review and hypotheticated pathogenesis. J Clin Diagn Res (2013) 0.82
Benefits of molecular pathology in the diagnosis of musculoskeletal disease : Part II of a two-part review: bone tumors and metabolic disorders. Skeletal Radiol (2009) 0.82
Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype. J Clin Pathol (1997) 0.82
Expression of CD34 and CD68 in peripheral giant cell granuloma and central giant cell granuloma: An immunohistochemical analysis. J Oral Maxillofac Pathol (2015) 0.81
Giant cell lesions of the craniofacial bones. Head Neck Pathol (2014) 0.79
Bisphosphonate treatment of benign multifocal and unifocal osteolytic tumours of bone. Sarcoma (2003) 0.78
An assessment of the ability of human bone marrow cultures to generate osteoclasts. Int J Exp Pathol (1992) 0.77
The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro. Int J Exp Pathol (1995) 0.76
IL-4 induces the formation of multinucleated giant cells and expression of β5 integrin in central giant cell lesion. Med Oral Patol Oral Cir Bucal (2016) 0.75
Clinical Management of a Peri-Implant Giant Cell Granuloma. Case Rep Dent (2015) 0.75
Management of central giant cell granuloma of the jaws with intralesional steroid injection and review of the literature. Oral Maxillofac Surg (2015) 0.75
Treatment of giant cell granuloma with intralesional corticosteroid injections: a case report. J Istanb Univ Fac Dent (2015) 0.75
An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 5.65
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol (1989) 4.46
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol (1994) 3.06
Cloning restriction fragments that promote expression of a gene in Bacillus subtilis. J Bacteriol (1981) 3.01
Drug-induced aplastic anemia. Semin Hematol (1973) 2.81
The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol (1987) 2.59
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37
Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis (1982) 2.36
Resorption of bone by isolated rabbit osteoclasts. J Cell Sci (1984) 2.33
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun (1994) 2.29
Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28
Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun (1992) 2.24
Nucleotide sequence of a Bacillus pumilus gene specifying chloramphenicol acetyltransferase. Gene (1983) 2.17
Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology (1996) 2.09
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
Calcitonin alters behaviour of isolated osteoclasts. J Pathol (1982) 2.06
Multinucleate giant cells. J Pathol (1978) 2.04
Colonic adenomas--a colonoscopy survey. Gut (1979) 2.01
Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using a monoclonal antibody against HLADR. J Oral Pathol Med (1991) 2.00
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet (2000) 1.96
Chloramphenicol-inducible gene expression in Bacillus subtilis. Gene (1983) 1.96
Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93
Genetic control of murine resistance to Toxoplasma gondii. Infect Immun (1978) 1.91
Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology (1996) 1.87
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun (1976) 1.85
Pulmonary infection in the compromised host: part I. Am Rev Respir Dis (1976) 1.82
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis (1982) 1.77
Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74
Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. Virology (1993) 1.70
Biodiversity at the molecular level: the domains, kingdoms and phyla of life. Philos Trans R Soc Lond B Biol Sci (1994) 1.67
Regulatory regions that control expression of two chloramphenicol-inducible cat genes cloned in Bacillus subtilis. J Bacteriol (1984) 1.66
Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. Virology (1994) 1.63
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63
Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis (1987) 1.59
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis (1981) 1.58
Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56
Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56
Streptococcal infection in piglets: the palatine tonsils as portals of entry for Streptococcus suis. Res Vet Sci (1973) 1.55
The granuloma in Crohn's disease. Gut (1979) 1.54
IADR Global Oral Health Inequalities Research Agenda (IADR-GOHIRA(R)): a call to action. J Dent Res (2013) 1.53
Ulcerlike lesions of the aorta: imaging features and natural history. Radiology (2001) 1.52
Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology (1986) 1.52
Surgical delay for acute type A dissection with malperfusion. Ann Thorac Surg (1997) 1.50
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med (1986) 1.50
Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49
Expression of Escherichia coli trp genes and the mouse dihydrofolate reductase gene cloned in Bacillus subtilis. Gene (1981) 1.49
Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol (1988) 1.49
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47
Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1984) 1.47
Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum. J Infect Dis (1990) 1.46
Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology (1989) 1.44
In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol (1996) 1.43
Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43
Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun (1991) 1.43
Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner (1990) 1.42
2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry (1992) 1.41
Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology (1995) 1.41
Portal hypertension in vinyl-chloride production workers. Lancet (1976) 1.40
Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet (1992) 1.40
Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy. Cardiovasc Intervent Radiol (1990) 1.39
The cellular basis of bone resorption. Clin Orthop Relat Res (1980) 1.38
Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology (1986) 1.37
A common protein binds to two silencers 5' to the human beta-globin gene. Nucleic Acids Res (1989) 1.36
The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology (1985) 1.35
Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1987) 1.33
Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun (1992) 1.33
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
Histoplasma capsulatum infection in nude mice. Infect Immun (1978) 1.31
Spiral CT of renal artery stenosis: comparison of three-dimensional rendering techniques. Radiology (1994) 1.29
Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity. Rev Infect Dis (1986) 1.29
Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28
EMG frequency content changes with increasing force and during fatigue in the quadriceps femoris muscle of men and women. J Electromyogr Kinesiol (2003) 1.27
Changes in the male voice at puberty. Arch Dis Child (1997) 1.27
Induction of NO and prostaglandin E2 in osteoblasts by wall-shear stress but not mechanical strain. Am J Physiol (1997) 1.26
Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone. Bone Miner (1989) 1.23
Isolation of the reaction center of Rhodopseudomonas viridis. Biochim Biophys Acta (1969) 1.23
Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone (1996) 1.23
Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol (1996) 1.23
The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells. J Pathol (1985) 1.23
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
Grey-scale ultrasonography for monitoring industrial exposure to hepatotoxic agents. Lancet (1975) 1.21